At Promega, we are interested in pursuing business development partnerships via in-licensing, and we also offer out-licensing of a number of key technologies. We have extensive experience developing a wide range of technologies for drug screening, biotechnology, clinical, academic and applied markets. Our broad portfolio includes industry-leading bioluminescent assays, nucleic acid purification systems for manual to automated research and clinical applications, and protein purification, pull-down and analysis solutions. We hold significant intellectual property rights and licenses in several key areas that form a foundation for our diverse portfolio.
For further information please contact firstname.lastname@example.org